RxDoctor Payments Data

Joseph Happel, MD

Internal Medicine · Fpo, AANPI 1669732798

Payments from drug & device makers

$292in general payments, 2019–2025

Across 18 payments — averaging $16.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$58
  • Aimmune Therapeutics, Inc.$46
  • Phathom Pharmaceuticals, Inc.$38
  • Novo Nordisk$35
  • AstraZeneca$33
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$25
  • plus $59 from 3 others

What the payments were for

  • Food & beverage$292100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

Too few internal medicine providers in AAto place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$15,313
Medicare patients
73
Services billed
333

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other internal medicine in Fpo

Where these figures come from

Is this you, or does something look wrong? →